Alvotech

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
BioSpace
Fri, 04/19/24 - 11:28 am
Alvotech
Teva Pharmaceutical
Humira
AbbVie
Simlandi
biosimilars
After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge
Fierce Pharma
Sun, 02/25/24 - 08:57 pm
Teva Pharmaceutical
Alvotech
AbbVie
Humira
biosmilars
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Thu, 10/12/23 - 10:22 am
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
BioSpace
Sun, 09/24/23 - 08:52 pm
FDA
ARS Pharmaceuticals
Novartis
Taysha
Alvotech
Intarcia
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Thu, 09/21/23 - 11:53 am
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Alvotech gets new FDA review for Humira biosimilar
BioPharma Dive
Wed, 09/20/23 - 11:07 pm
Alvotech
FDA
Humira
biosimilars
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Mon, 07/24/23 - 09:35 pm
Teva Pharmaceutical
Alvotech
biosimilars
Humira
AbbVie
drug manufacturing
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Alvotech
Teva Pharmaceutical
AbbVie
Humira
biosimilars
FDA
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA
Business Insider
Mon, 04/17/23 - 11:06 pm
Teva Pharmaceutical
Alvotech
AVT02
FDA
Humira
biosimilars
FDA rejects Teva’s high-potency biosimilar of Humira again
Pharmaphorum
Fri, 04/14/23 - 10:37 am
Teva Pharmaceutical
Alvotech
biosimilars
FDA
Humira
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
FDA holds back Alvotech’s Humira biosimilar over manufacturing issues
BioPharma Dive
Tue, 09/6/22 - 04:57 pm
Alvotech
AbbVie
Humira
biosimilars
FDA
drug manufacturing
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
BioSpace
Thu, 07/7/22 - 10:41 am
Alvotech
AVT06
biosimilars
clinical trials
Eylea
J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win
Fierce Pharma
Tue, 05/24/22 - 04:31 pm
Alvotech
Teva Pharmaceutical
JNJ
Stelara
AVT04
biosimilars
psoriasis
AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year
Fierce Pharma
Wed, 03/9/22 - 10:46 am
Alvotech
AbbVie
Humira
biosimilars
legals
patents
trade secrets
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Fierce Pharma
Tue, 12/7/21 - 11:07 am
Alvotech
SPACs
AbbVie
Humira
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Fierce Pharma
Fri, 10/8/21 - 10:32 am
Alvotech
AbbVie
patents
Humira
trade secrets
biosimilars
AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira
Endpoints
Mon, 05/24/21 - 11:30 pm
AbbVie
biosimilars
Humira
Alvotech

Pages